Sustained, Proactive Biomedical Research Investment Essential To Preventing Future Outbreaks

CNBC: Here’s how we prevent the next killer virus
Claire Pomeroy, president of the Albert and Mary Lasker Foundation

“…The lesson from Ebola — and before that, from HIV/AIDS — should have been that research to find treatments and vaccines requires sustained, proactive investment. The alternative, i.e., formulating solutions in the heat of a health crisis, is dangerously inadequate; reacting to each outbreak instead of consistently funding research means that we will always be behind, never ahead of the crisis. … Instead of shuttering labs and cutting back on promising research, we need to spend the money now and [sustain funding] into the future — proactively — to understand more about basic virology, immunology, and epidemiology; to develop vaccine platforms; and to translate those insights into development of new vaccines and therapies…” (4/4).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.